Effect of screening for undiagnosed COPD on respiratory hospitalisation and mortality; 4 year follow up of the TargetCOPD trial

P. Adab (Birmingham, United Kingdom), D. Fitzmaurice (Warwick, United Kingdom), J. Martin (Birmingham, United Kingdom), A. Sitch (Birmingham, United Kingdom), K. Cheng (Birmingham, United Kingdom), A. Daley (Loughborough, United Kingdom), A. Dickens (Birmingham, United Kingdom), A. Enocson (Birmingham, United Kingdom), S. Greenfield (Birmingham, United Kingdom), K. Jolly (Birmingham, United Kingdom), S. Jowett (Birmingham, United Kingdom), M. Miller (Birmingham, United Kingdom), R. Riley (Keele, United Kingdom), S. Siebert (Birmingham, United Kingdom), R. Stockley (Birmingham, United Kingdom), A. Turner (Birmingham, United Kingdom), S. Haroon (Birmingham, United Kingdom), R. Jordan (Birmingham, United Kingdom)

Source: International Congress 2019 – Management of airway diseases in primary care
Session: Management of airway diseases in primary care
Session type: Oral Presentation
Number: 5147
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Adab (Birmingham, United Kingdom), D. Fitzmaurice (Warwick, United Kingdom), J. Martin (Birmingham, United Kingdom), A. Sitch (Birmingham, United Kingdom), K. Cheng (Birmingham, United Kingdom), A. Daley (Loughborough, United Kingdom), A. Dickens (Birmingham, United Kingdom), A. Enocson (Birmingham, United Kingdom), S. Greenfield (Birmingham, United Kingdom), K. Jolly (Birmingham, United Kingdom), S. Jowett (Birmingham, United Kingdom), M. Miller (Birmingham, United Kingdom), R. Riley (Keele, United Kingdom), S. Siebert (Birmingham, United Kingdom), R. Stockley (Birmingham, United Kingdom), A. Turner (Birmingham, United Kingdom), S. Haroon (Birmingham, United Kingdom), R. Jordan (Birmingham, United Kingdom). Effect of screening for undiagnosed COPD on respiratory hospitalisation and mortality; 4 year follow up of the TargetCOPD trial. 5147

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study
Source: Annual Congress 2011 - COPD management
Year: 2011

Non-invasive ventilation (NIV) and mortality in patients with a first-time admission for a COPD exacerbation: A nationwide study
Source: Annual Congress 2013 –New evidence for NIV in the acute setting
Year: 2013


One year follow up in COPD with oxygen: mortality and hospitalization
Source: Eur Respir J 2005; 26: Suppl. 49, 291s
Year: 2005

COPD exacerbation phenotypes in a five year hospitalisation cohort
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018



Long-term follow-up of the ISOLDE participants: causes of death after 13 years of the trial completion
Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer
Year: 2007


Predictors of mortality in COPD patients after hospitalization due to an exacerbation
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019


Impact of frailty during hospitalized exacerbations of COPD on 90-day readmissions - preliminary data.
Source: International Congress 2018 – Physiotherapy care for patients with acute and chronic respiratory conditions
Year: 2018



Factors affecting one year mortality of hospitalized patients with COPD exacerbation and respiratory failure
Source: Eur Respir J 2007; 30: Suppl. 51, 321s
Year: 2007

Trends in the lifetime risk of COPD exacerbation requiring hospitalisation
Source: Eur Respir J 2013; 42: 964-971
Year: 2013



RSV increases the risk of first paediatric asthma hospitalisation: whole-of-population cohort study
Source: International Congress 2017 – Determinants of childhood asthma and atopy
Year: 2017




Effect of non-invasive mechanical ventilation on exacerbations in patients with stable COPD: A 4 year cohort study with one year follow-up
Source: International Congress 2015 – Novelties in noninvasive ventilation
Year: 2015

AUDIPOC. National clinical audit on chronic obstructive pulmonary disease exacerbations (eEPOC) in Spain. Mortality and readmission at 90 days of patients admitted for eEPOC. Influence of hospitalization department
Source: Annual Congress 2009 - Healthcare and treatment of COPD
Year: 2009

Predictors of long-term mortality after hospitalization for COPD; A Scandinavian multicentre study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014

Regular follow-up visits reduce the risk for severe asthma exacerbation required admission
Source: International Congress 2017 – Chronic airway disease: markers of disease impact
Year: 2017


Direct cost analysis of COPD patients: A 1 year follow-up study
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016


In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality
Source: International Congress 2015 – COPD: interesting notes
Year: 2015

Predictors of 1-year mortality at hospital admission for acute exacerbations of COPD – A real-life study
Source: Annual Congress 2012 - Multidisciplinary critical care
Year: 2012


Risk factors associated to COPD worsening in Italian general practices: The 12 month COMODHES follow-up study
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014

Impact of home hospitalization on treatment compliance in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 207s
Year: 2001

Pharmacological management and risk of mortality after first COPD hospitalization (HERA)
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020